Test cyclosporine versus steroids for DRESS skin reaction
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial compares two medicines—cyclosporine and steroid treatment—for a rare, serious drug reaction called DRESS. It aims to see which treatment controls the illness more safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18+ years old).
- Your DRESS diagnosis is likely based on a RegiSCAR score higher than 4.
- You do not have active sepsis (a dangerous body-wide infection).
- You do not have active hepatitis B or C, or active tuberculosis.
- You are not allergic to steroids or cyclosporine.
- Your kidney function is not too low (eGFR is 30 or higher), unless you are on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how certain immune cells (eosinophils) behave during severe drug reactions like DRESS and during milder drug rashes. It may help doctors understand what drives organ damage and improve how these reactions are managed.
This trial tests a targeted therapy for people with a severe drug reaction called DRESS syndrome. It may help control the overactive immune response and reduce organ damage.
This study collects skin and blood samples from adults who have a serious rash caused by medicines. The goal is to better understand these reactions and how to diagnose them sooner and more accurately.
This trial tests a combination of a steroid (methylprednisolone) and a JAK inhibitor to treat toxic epidermal necrolysis, a severe skin reaction. The goal is to see if adding the JAK inhibitor helps improve outcomes and safety.
This trial tests whether rituximab works as well as mycophenolate in children whose nephrotic syndrome (kidney condition) comes back when steroid medicines are reduced. It aims to find the safest and most effective option during a relapse.
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
Hear when a new DRESS Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.